Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

4,330 Journal Article Views | Journal Analytics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper



Publication Date: 16 Mar 2010

Type: Review

Journal: Clinical Medicine Reviews in Therapeutics

Citation: Clinical Medicine Reviews in Therapeutics 2010:2

doi: 10.4137/CMRT.S1600

Abstract

Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.


Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)






What Your Colleagues Say About Libertas Academica
Publishing in Air, Soil and Water and Water Research was the best experience I have had so far in an academic context.  The review process was fair, quick and efficient.  I congratulate the team at Libertas Academica for a very well managed journal.
Magnus Karlsson (IVL Swedish Environmental Research Institute, Stockholm, Sweden)
More Testimonials

Quick Links


New article and journal news notification services